微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.45% | 48.7% | 38.99% | 44/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.36% | 79.26% | 103.03% | 32/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.64% | 53.49% | -55.56% | 43/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.94% | -4.81% | 18.56% | 52/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.01% | 3.51% | 67.56% | 71/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.99% | 34.08% | 73.84% | 69/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.72% | 91.11% | -72.44% | 67/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 6.24% | 4.87% | 28.93% | 66/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.84% | -35.64% | 117.04% | 66/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.23% | -54.86% | 147.78% | 84/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.9% | -66.42% | -84.87% | 96/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.95% | -9.44% | -20.88% | 70/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 7.52% | -6.23% | 52.23% | 58/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.94% | 42.36% | 84.33% | 56/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.68% | 51.41% | -59.21% | 49/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 6.57% | -19.29% | -18.08% | 75/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.02% | -1.6% | 131.12% | 49/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 3.47% | -31.15% | 96.05% | 71/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.77% | -33.96% | -78.26% | 55/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.14% | 26.01% | -0.12% | 71/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 8.15% | -9.04% | 61.71% | 45/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.04% | -17.38% | 88.06% | 49/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.68% | -3.25% | -58.51% | 40/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.46% | -10.9% | -27.9% | 74/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.96% | 17.74% | 46.89% | 31/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 6.1% | 5.72% | 120.22% | 29/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.77% | 0.36% | -61.79% | 34/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.25% | -28.57% | -4.73% | 71/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 7.61% | -21.79% | 31.89% | 46/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.77% | 227.84% | 109.06% | 36/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.76% | 5.34% | -72.81% | 33/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 10.15% | -39.4% | 4.32% | 58/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.73% | -14.42% | 452.84% | 24/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 1.76% | -81.16% | -32.82% | 72/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.62% | -40.59% | -84.36% | 31/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 16.75% | 16.64% | 47.32% | 30/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 11.37% | -3.64% | 21.73% | 19/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 9.34% | 4.83% | 111.79% | 15/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.41% | 12.5% | -69.29% | 15/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 14.36% | 45.49% | 21.69% | 37/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 11.8% | 36.73% | 32.44% | 14/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 8.91% | 31.03% | 127.3% | 10/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 3.92% | 18.43% | -60.28% | 15/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |